bayer

Register to receive a free European Market Report Suite for Gynecological Devices report synopsis and brochure

According to a new series of reports on the European gynecological device market by iData Research, the predominant trend in the European market is to invest in less-invasive, office based procedures. As a result, lasers have become the fastest growing gynecological market in the region. The untapped potential for these devices for smaller clinics and medical offices investing in capital equipment is fueling growth in a struggling European economy. This has resulted in higher unit sales and an associated growth in market value.

Despite downward economic pressures, price erosion and government regulations, assisted reproduction and laser technology are the fastest growing markets. For example, in Italy, the country is leading the adoption of gynecological laser technology, but the market value of assisted reproduction is quelled due to local laws. On the other hand, the U.K. is advancing assisted reproduction technology, therefore stabilizing growth in the overall market.

“The largest trend in the general laser market is the transition from dermatologists performing non-invasive, in-office laser procedures to gynecologists starting to invest in the technology,” explains Dr. Kamran Zamanian, CEO of iData. “With patient safety at the forefront, the erosion of other markets in favor of laser treatments for dyspareunia and urinary incontinence is shifting the market towards minimally invasive technologies.”

Bayer is the leader in the European gynecological device market due to the company’s exclusive hold on the transcervical female sterilization market throughout Europe. Karl Storz is the seconding leading competitor offering a diverse product portfolio as market leader in endometrial resection devices, hysteroscopes and fluid management equipment. The partnership between Karl Storz and Medical Technical Promotion gmbh (MTP) has contributed to the company’s strong growth and consistent sales in a recovering economy.

Similar to Karl Storz, Cooper Surgical holds a diverse line of products involved in multiple markets including assisted reproductive technologies, colposcopes, female sterilization devices and HSG catheters. Cooper Surgical’s acquisition of micropipette maker ORIGIO in June 2012 cemented the company’s lead in the assisted reproduction technology market. They expanded their presence within the embryo transfer catheter segment with this acquisition. The company’s growth is projected to remain stable through 2022.

Additional competitors in the European gynecological device market include Johnson & Johnson, Olympus, Richard Wolf, Cook Medical, Astora Women’s Health, Vitrolife, Boston Scientific, Hologic, Coloplast, Deka, CR Bard, Medtronic, Carl Zeiss, Smiths Medical, AlmaSurgical, Fotona, CCD and Kaps Optik GmbH among others.

For Further Information
More on the gynecological device market in Europe can be found in a series of reports published by iData Research entitled the European Market Report Suite for Gynecological Devices.